Pharmafile Logo
Pharmafocus logo
Advanced Search

Bayer

Showing 15 posts of 262 posts found.

Bayer announces major restructure, 12,000 jobs to go

November 30, 2018
Medical Communications, Sales and Marketing Bayer, job cuts, monsanto, pharma

Bayer has announced a major restructure of its operations in 2019 which will see the loss of 12,000 of its …

News

NICE recommends Bayer’s Stivarga for advanced hepatocellular carcinoma

November 29, 2018
Sales and Marketing Bayer, NICE, Stivarga, UK, pharma

The National Institute for Health and Care Excellence (NICE) has voiced its recommendation for Bayer’s Stivarga (regorafenib) for use on …

News
bayercross3

Bayer’s Jivi approved in Europe for previously treated haemophilia A

November 28, 2018
Research and Development, Sales and Marketing Bayer, Jivi, haemophilia, pharma

Bayer has revealed that its recombinant Factor VIII (rFVIII) replacement therapy Jivi, also known as BAY94-9027, has received approval from …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

October 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AstraZeneca, Bayer, Novartis, Samsung, Trump, biosimilars, brexit

Business, biosimilars and Brexit are the themes of this week’s top 10. While Roche signed a $1 billion deal with …

News
Bayer image

Novartis and Bayer seek to oppose High Court ruling over NHS decision to use cheaper drug

October 16, 2018
Manufacturing and Production Bayer, CCG, NHS, Novartis, avastin, wet AMD

Swiss multinational Novartis have joined German pharma firm Bayer in appealing a High Court ruling over 12 NHS clinical commissioning …

News
martin_van_trieste

Non-profit generic drug company Civica Rx appoints former Amgen quality chief as new CEO

October 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbot, Amgen, Bayer, civica rx, generic drugs, hospitals

Civica Rx, a new not-for-profit generic drug company aimed at reducing the price of lifesaving medicines, has appointed former Amgen …

Appointment

Bayer to cut 227 positions in California to drive efficiency in haemophilia

October 4, 2018
Manufacturing and Production Bayer, haemophilia, pharma

Bayer has announced its intention to axe 227 employees at a manufacturing site in California as part of a push …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 28, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, NHS, Novartis, pharma

Life expectancy was a key topic this week, as it emerged that growth has stalled and even fallen in areas …

News

Courts back NHS in fight against Novartis and Bayer

September 24, 2018
Sales and Marketing Bayer, Eylea, NHS, Novartis, avastin, ludentis

The NHS has won a court case against multinational pharmaceutical firms Novartis and Bayer, after the companies sought to block …

News
ipos0_l

Regeneron’s Eylea wins FDA approval for wet age-related macular degeneration

August 20, 2018
Sales and Marketing Bayer, Eylea, FDA, Regeneron, US, pharma

Regeneron is celebrating the approval in the US of its vascular endothelial growth factor (VEGF) inhibitor Eylea (aflibercept) for the …

News
Bayer

Bayer expands Broad Institute partnership to focus on heart failure

July 3, 2018
Manufacturing and Production, Research and Development Bayer, broad institute, collaboration, heart failure, pharma

The Broad Institute of MIT and Harvard has expanded its partnership with Bayer through the launch of the Precision Cardiology …

News
bayer_cross_2

Bayer eyes R&D cuts, as Monsanto deal raises question of focus

June 1, 2018
Medical Communications Bayer, biotech, drugs, monsanto, pharma, pharmaceutical

When rumours first started rumbling about a mega-merger between Bayer and Monsanto, one of the major question marks was on …

News
essure

Bayer contraceptive implant public backlash brings results

April 12, 2018
Medical Communications, Sales and Marketing Bayer, Essure, biotech, drugs, pharma, pharmaceutical

Bayer’s permanent contraceptive device, Essure, has been at the centre of a public backlash for a number of years, with …

News
bayer_cross_2

Bayer-Monsanto deal one step closer, after EU nod

March 22, 2018
Sales and Marketing Bayer, EU, biotech, drugs, monsanto, pharma, pharmaceutical

The merger between Bayer and agricultural giant, Monsanto, is inching closer to completion after the EU Commission won EU antitrust …

News

NICE recommends thyroid cancer drug trio for NHS use

February 20, 2018
Manufacturing and Production, Sales and Marketing Bayer, Cancer, Cometriq, Eisai, Lenvima, NICE, Nexavar, ipsen, pharma, thyroid cancer

NICE has announced its decision to recommend that three separate treatments for thyroid cancer should be made available for use …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025